Vanda Pharmaceuticals Statistics
Total Valuation
VNDA has a market cap or net worth of $257.63 million. The enterprise value is -$53.92 million.
Important Dates
The last earnings date was Thursday, July 31, 2025, before market open.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
VNDA has 59.09 million shares outstanding. The number of shares has increased by 1.34% in one year.
Current Share Class | 59.09M |
Shares Outstanding | 59.09M |
Shares Change (YoY) | +1.34% |
Shares Change (QoQ) | +0.80% |
Owned by Insiders (%) | 5.14% |
Owned by Institutions (%) | 66.29% |
Float | 49.36M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.24 |
Forward PS | 0.94 |
PB Ratio | 0.52 |
P/TBV Ratio | 0.69 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.02.
Current Ratio | 3.25 |
Quick Ratio | 3.05 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -52.37 |
Financial Efficiency
Return on equity (ROE) is -13.01% and return on invested capital (ROIC) is -12.01%.
Return on Equity (ROE) | -13.01% |
Return on Assets (ROA) | -9.87% |
Return on Invested Capital (ROIC) | -12.01% |
Return on Capital Employed (ROCE) | -20.03% |
Revenue Per Employee | $552,899 |
Profits Per Employee | -$181,894 |
Employee Count | 368 |
Asset Turnover | 0.32 |
Inventory Turnover | 6.27 |
Taxes
Income Tax | -18.06M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.01% in the last 52 weeks. The beta is 0.72, so VNDA's price volatility has been lower than the market average.
Beta (5Y) | 0.72 |
52-Week Price Change | -15.01% |
50-Day Moving Average | 4.60 |
200-Day Moving Average | 4.61 |
Relative Strength Index (RSI) | 44.10 |
Average Volume (20 Days) | 507,754 |
Short Selling Information
The latest short interest is 4.53 million, so 7.67% of the outstanding shares have been sold short.
Short Interest | 4.53M |
Short Previous Month | 4.59M |
Short % of Shares Out | 7.67% |
Short % of Float | 9.18% |
Short Ratio (days to cover) | 8.86 |
Income Statement
In the last 12 months, VNDA had revenue of $203.47 million and -$66.94 million in losses. Loss per share was -$1.14.
Revenue | 203.47M |
Gross Profit | 192.07M |
Operating Income | -100.81M |
Pretax Income | -11.96M |
Net Income | -66.94M |
EBITDA | -92.87M |
EBIT | -100.81M |
Loss Per Share | -$1.14 |
Full Income Statement Balance Sheet
The company has $325.55 million in cash and $11.64 million in debt, giving a net cash position of $313.91 million or $5.31 per share.
Cash & Cash Equivalents | 325.55M |
Total Debt | 11.64M |
Net Cash | 313.91M |
Net Cash Per Share | $5.31 |
Equity (Book Value) | 486.33M |
Book Value Per Share | 8.23 |
Working Capital | 273.43M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$64.80 million and capital expenditures -$1.11 million, giving a free cash flow of -$65.91 million.
Operating Cash Flow | -64.80M |
Capital Expenditures | -1.11M |
Free Cash Flow | -65.91M |
FCF Per Share | -$1.12 |
Full Cash Flow Statement Margins
Gross margin is 94.40%, with operating and profit margins of -49.55% and -32.90%.
Gross Margin | 94.40% |
Operating Margin | -49.55% |
Pretax Margin | -41.77% |
Profit Margin | -32.90% |
EBITDA Margin | -45.64% |
EBIT Margin | -49.55% |
FCF Margin | n/a |
Dividends & Yields
VNDA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.34% |
Shareholder Yield | -1.34% |
Earnings Yield | -25.75% |
FCF Yield | -25.35% |
Analyst Forecast
The average price target for VNDA is $16.50, which is 278.44% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $16.50 |
Price Target Difference | 278.44% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
VNDA has an Altman Z-Score of 1.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.02 |
Piotroski F-Score | 3 |